Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cationic corticosteroid for nonviral gene delivery.

J A Gruneich1, A Price, J Zhu

  • 111024 Vagelos Research Laboratory, Department of Bioengineering, Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia 19104, USA.

Gene Therapy
|January 16, 2004
PubMed
Summary

A novel dexamethasone-spermine (DS) cationic lipid enhances gene delivery by reducing inflammation and improving transgene expression. This pharmacophore offers a new approach for gene therapy and localized treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Failure of the femoral stem: A case series of intra-prosthetic fractures and proposed classification system.

Journal of orthopaedics·2026
Same author

Pain after lower limb amputation.

BJA education·2026
Same author

Implementation considerations for integrated face and respiratory protection: a qualitative study.

The Journal of hospital infection·2025
Same author

The risk of revision surgery after trainee-led primary total hip replacement.

Annals of the Royal College of Surgeons of England·2024
Same author

Molecular signatures of cortical expansion in the human foetal brain.

Nature communications·2024
Same author

Molecular signatures of cortical expansion in the human fetal brain.

bioRxiv : the preprint server for biology·2024

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Pharmacology

Background:

  • Gene therapy delivery using plasmid DNA often triggers inflammatory responses, hindering transgene expression.
  • Current cationic lipids for gene transfer lack inherent pharmacological activity, limiting therapeutic potential.

Purpose of the Study:

  • To synthesize and characterize a novel water-soluble cationic lipid, dexamethasone-spermine (DS), with combined gene transfer and anti-inflammatory properties.
  • To evaluate the efficacy of DS in gene delivery and its impact on inflammatory responses in preclinical models.

Main Methods:

  • One-step synthesis of dexamethasone-spermine (DS) cationic lipid.
  • Assessment of gene transfer capability in endothelial cells using DS with dioleoylphosphatidylethanolamine (DOPE).

Related Experiment Videos

  • Evaluation of corticosteroid activity, in vivo anti-inflammatory effects, and gene delivery efficiency in mouse models.

    • Main Results:

    • DS demonstrated potent gene transfer capability in endothelial cells, superior to unconjugated components.
    • DS retained partial corticosteroid activity, inducing glucocorticoid receptor translocation and transactivation.
    • DS:DOPE formulations showed reduced interferon-gamma production and enhanced transgene expression in a mouse lung model compared to DC-Chol:DOPE.

    Conclusions:

    • Dexamethasone-spermine (DS) is a novel cationic lipid with dual gene delivery and anti-inflammatory functions.
    • DS represents a promising new strategy for developing effective gene therapy vectors and localized therapeutic agents.